Y-Intercept (Hong Kong) Ltd

Position in HIMS — Hims & Hers Health, Inc.

CIK 1772875 HONG KONG, K3

Position in HIMS

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$6,592,327

-$7,126,482 QoQ

Shares Held

190,145

-21.4% QoQ

Ownership

0.082%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

of 32 holders

Holding Since

Dec 2021

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Jun 30, 2026

Y-Intercept (Hong Kong) Ltd holds $54,645,005 across 16 Drug Manufacturers - Specialty & Generic names. HIMS ranks #3 (12.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	147,055	$10,567,372
2	UTHR	UNITED THERAPEUTICS Corp	14,271	$7,732,455
3	HIMS	Hims & Hers Health, Inc. This page	190,145	$6,592,327
4	INDV	Indivior Pharmaceuticals, Inc.	136,725	$5,609,826
5	VTRS	Viatris Inc	331,130	$5,258,344
6	PRGO	PERRIGO Co plc	346,586	$3,601,028
7	XERS	Xeris Biopharma Holdings, Inc.	411,346	$3,257,860
8	ANIP	Ani Pharmaceuticals Inc	34,505	$2,856,323

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,592,327	190,145	-21.4%	Shares	Sole	2026-07-14
2025-09-30	$13,718,809	241,869	+131.2%	Shares	Sole	2025-10-31
2025-06-30	$5,214,310	104,600	+62.4%	Shares	Sole	2025-08-01
2025-03-31	$1,903,433	64,414	-51.9%	Shares	Sole	2025-05-06
2024-09-30	$2,468,611	134,018	+312.6%	Shares	Sole	2024-11-15
2024-06-30	$655,811	32,482	-19.7%	Shares	Sole	2024-08-14
2024-03-31	$626,024	40,467	+19.0%	Shares	Sole	2024-05-10
2023-03-31	$337,458	34,018	+234.7%	Shares	Sole	2023-05-09
2021-12-31	$66,567	10,163	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.